2 Underrated Biotech Stocks to Buy Now

2 Underrated Biotech Stocks to Buy Now

Leading rare-disease player Alexion Pharmaceuticals (NASDAQ: ALXN) and neuropsychiatric disorder specialist Intra-Cellular Therapies (NASDAQ: ITCI) are both poised for an upward trajectory in coming months. Alexion Pharmaceuticals is a rare gem in the biotech industry. The company's focus on rare and ultra-rare diseases means that it is working with a very small patient pool.